⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,722.51
+0.41%
Nasdaq 100
29,573.90
+0.15%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$217.33
+0.11%
NYSE:TSM
$427.60
+1.76%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,125.97
−0.36%
Brent
$108.50
−0.66%
BTC
$82,682.55
+1.03%
ETH
$2,445.95
+1.69%
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,722.51
+0.41%
Nasdaq 100
29,573.90
+0.15%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$217.33
+0.11%
NYSE:TSM
$427.60
+1.76%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,125.97
−0.36%
Brent
$108.50
−0.66%
BTC
$82,682.55
+1.03%
ETH
$2,445.95
+1.69%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Pfizer Inc · News · TradingHolo
Markets
›
United States
› NYSE
› PFE
P
Pfizer Inc
NYSE:PFE
Healthcare
CBOE:SPESG
STOXX:EDD24BP
$30.11
+2.28%
Live
In session · ≈
AED 110.58
· Market cap
$171.62B
· Next earnings
Tue 3 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
PFE news
Headlines tagged to this company
BE
Merck Just Raised the Stakes for Pfizer's Cancer Vaccine Ambitions
Benzinga · 62 d ago
ZA
Pfizer's Obesity Push: Can Berobenatide Take Market Share?
Zacks Investment Research · 62 d ago
SE
Valneva: The Lyme Royalty Transition Changes The Earnings Model
Seeking Alpha · 64 d ago
BA
Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase
Barrons · 67 d ago
BE
European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application
Benzinga · 67 d ago
FA
Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money
Fast Company · 67 d ago
GL
Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
GlobeNewsWire · 68 d ago
ZA
Will Pfizer's Non-COVID Portfolio Drive Its Next Phase of Growth?
Zacks Investment Research · 69 d ago
SE
Pfizer's Pipeline Could Change Everything
Seeking Alpha · 70 d ago
FO
Pfizer Just Raised Its 2026 Guidance -- but the Boost Leans Heavily on a Drug Running Out the Patent Clock
Fool - Investing News · 70 d ago
TH
Pfizer's Earnings Have Declined 58% This Year. Is a Dividend Cut Around the Corner?
The Motley Fool · 71 d ago
TH
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound
The Motley Fool · 74 d ago
FI
Monster insider trading alert for Pfizer stock
Finbold · 74 d ago
24
After Q2 Earnings, Is Pfizer or Merck the Smarter Dividend Play?
24/7 Wall Street · 75 d ago
SE
Pfizer: Q2 Strength Overshadows Obesity Setbacks
Seeking Alpha · 75 d ago
BU
Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance
Business Wire · 77 d ago
BU
Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo
Business Wire · 82 d ago
GL
Europäische Kommission genehmigt Marktzulassung des an XFG angepassten COVID-19-Impfstoffs von Pfizer und BioNTech in der Europäischen Union
Globe News Wire · 83 d ago
GL
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
Globe News Wire · 83 d ago
← Previous
End of the feed